Viemed Healthcare Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	13.5	17.54	12.84	16.91	28.41
Cash & Short-Term Investments	13.5	17.54	12.84	16.91	28.41
Cash Growth	-23.03%	36.61%	-24.09%	-40.46%	-8.30%
Accounts Receivable	25.59	24.91	18.45	15.38	12.82
Other Receivables	0.23	-	-	0.03	1.89
Total Trade Receivables	25.81	24.91	18.45	15.41	14.72
Inventory	5.05	4.32	4.63	3.57	2.46
Other Current Assets	4.13	6.11	2.45	3.85	1.73
Total Current Assets	48.49	52.88	38.37	39.74	47.31
Net Property, Plant & Equipment	82.36	79.16	76.85	68.44	62.85
Other Intangible Assets	1.29	0.85	0.57	-	-
Goodwill	58.94	32.99	29.77	-	-
Long-Term Investments	2.79	2.79	3.9	4.16	2.16
Other Long-Term Assets	5.29	8.4	5.45	4.71	5.65
Total Assets	199.15	177.07	154.9	117.04	117.96
Accounts Payable	7.33	5.32	4.18	2.65	3.24
Accrued Expenses	23.91	20.16	17.58	11.09	8.88
Current Portion of Long-Term Debt	1.09	0.41	1.07	-	1.48
Current Portion of Leases	1.2	0.86	0.93	0.5	0.46
Unearned Revenue	7.52	6.69	6.21	4.62	3.75
Other Current Liabilities	-	3.88	2.15	-	-
Total Current Liabilities	41.06	37.33	32.12	18.86	17.81
Long-Term Debt	11.29	3.59	6	-	4.31
Long-Term Leases	2.36	2.01	2.32	0.2	0.27
Other Long-Term Liabilities	0.92	0.85	0.56	0.89	0.76
Total Long-Term Liabilities	14.58	6.44	8.88	1.09	5.33
Total Liabilities	55.63	43.77	41	19.95	23.14
Common Stock	16.91	23.37	18.7	15.12	14.01
Additional Paid-in Capital	21.74	18.34	15.7	12.13	7.75
Accumulated Other Comprehensive Income	-	-	-	-	-0.28
Retained Earnings	102.89	89.69	79.5	69.85	73.34
Total Common Shareholders' Equity	141.55	131.39	113.9	97.09	94.82
Minority Interest	1.98	1.91	-	-	-
Shareholders' Equity	143.52	133.3	113.9	97.09	94.82
Total Liabilities & Equity	199.15	177.07	154.9	117.04	117.96
Total Debt	15.95	6.87	10.32	0.69	6.52
Net Cash (Debt)	-2.45	10.67	2.52	16.22	21.89
Net Cash Growth	-	324.41%	-84.49%	-25.90%	10.30%
Net Cash Per Share	-0.06	0.26	0.06	0.41	0.54
Book Value	141.55	131.39	113.9	97.09	94.82
Book Value Per Share	3.47	3.22	2.82	2.44	2.33
Tangible Book Value	81.32	97.56	83.56	97.09	94.82
Tangible Book Value Per Share	1.99	2.39	2.07	2.44	2.33

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q